US20120134935A1 - Use of mometasone furoate for treating airway passage and lung disease - Google Patents

Use of mometasone furoate for treating airway passage and lung disease Download PDF

Info

Publication number
US20120134935A1
US20120134935A1 US13/366,971 US201213366971A US2012134935A1 US 20120134935 A1 US20120134935 A1 US 20120134935A1 US 201213366971 A US201213366971 A US 201213366971A US 2012134935 A1 US2012134935 A1 US 2012134935A1
Authority
US
United States
Prior art keywords
mometasone furoate
method
day
disease
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/366,971
Inventor
Joel A. Sequeira
Francis M. Cuss
Keith B. Nolop
Imtiaz A. Chaudry
Nagamani NAGABJUSHAN
James E. Patrick
Mitchell Cayen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US18837294A priority Critical
Priority to US37650695A priority
Priority to US44458295A priority
Priority to US70066496A priority
Priority to US70153696A priority
Priority to US08/821,135 priority patent/US5837699A/en
Priority to US08/911,300 priority patent/US5889015A/en
Priority to US09/259,721 priority patent/US6057307A/en
Priority to US09/535,208 priority patent/US6365581B1/en
Priority to US10/053,204 priority patent/US6677323B2/en
Priority to US10/050,396 priority patent/US6677322B2/en
Priority to US10/426,329 priority patent/US6723713B2/en
Priority to US10/763,295 priority patent/US6949532B2/en
Priority to US10/763,143 priority patent/US6956030B2/en
Priority to US11/210,409 priority patent/US20050287080A1/en
Priority to US12/575,356 priority patent/US20100022493A1/en
Application filed by Merck Sharp and Dohme Corp filed Critical Merck Sharp and Dohme Corp
Priority to US13/366,971 priority patent/US20120134935A1/en
Publication of US20120134935A1 publication Critical patent/US20120134935A1/en
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCHERING CORPORATION
Application status is Abandoned legal-status Critical

Links